共 50 条
- [31] Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin and Aspirin for Stroke Prevention Atrial Fibrillation (SPAF) in the Indonesian healthcare setting INDONESIAN JOURNAL OF PHARMACY, 2019, 30 (01): : 74 - 84
- [33] Who Gets Stroke Prevention? Stroke Prevention in Atrial Fibrillation Patients in the Inpatient Setting HEART LUNG AND CIRCULATION, 2015, 24 (05): : 488 - 494
- [35] Atrial fibrillation: primary prevention, secondary prevention, and prevention of thromboembolic complications: part 1 FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
- [36] Atrial fibrillation: Primary prevention, secondary prevention, and prevention of thromboembolic complications: Part 2 FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 9
- [37] Primary Prevention of Arterial Thromboembolism in Nonrheumatic Atrial Fibrillation: The PATAF trial study design CONTROLLED CLINICAL TRIALS, 1999, 20 (04): : 386 - 393
- [39] STUDY ON PREVENTION OF EMBOLISM IN NONVALVULAR ATRIAL FIBRILLATION HEART, 2012, 98 : E263 - E264